The objective of this project is the identification of recurrent genetic alterations that are relevant to the neoplastic development and provide markers for an early detection and prognostic assessment of cancer, particularly in solid tumors. Localization of genes is essential for molecular analysis of chromosomal alterations in cancer cells and for the identification of specific disease loci. In July 1996 a new Molecular Cytogenetics Section was established in LEC. The research program of this Section focused primarily on human and induced hepatic cancer in mice. Certain genomic regions exhibit an increase fragility and tendency to recombination due to structural chromatin organization and DNA replication A fragile site of the short arm of chromosome 3 (FRA3B) is frequently associated with deletions, translocations and virus integration in several forms of cancer. FRA3B encompasses the locus of the fragile histidine triad (FHIT) gene, a multiple tumor suppressor gene which is abnormally expressed in a variety of common forms of cancer. By FISH, using cosmids covering specific regions of the FHIT gene, it was found that most of the aphidicolin-induced gaps at FRA3B fall within the FHIT gene. These results demonstrate that the cancer-specific deletions, which frequently involve introns 4 and 5 of the FHIT gene, originated through breaks in FRA3B. Also, sequences that are prone to damage and recombination at a critical site in human cancer were identified at the intragenic level. Keratinocyte growth factor (KGF) is a member of the fibroblast growth factor family. Portions of the gene encoding KGF were amplified during primate evolution and are present in multiple non-processed copies in the human genome. KGF sequences were identified and mapped in human and great apes providing insights in the dating of amplification and dispersion events that began in gibbon. Most importantly, evidence for a closer evolutionary relationship of human and chimpanzee and a possible selective pressure for such dispersion during the evolution of higher primates were provided. The localization of several newly isolated cancer-related genes for frizzled-related protein, ninjurin, mouse cyclin G1 and dipeptidyl I peptidase genes, and three glial-derived neurotrophic factor genes is of special importance as it will facilitate the identification of loci in genetic diseases of unknown etiology mapping at the same chromosomal regions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010038-03
Application #
6101029
Study Section
Special Emphasis Panel (LEC)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Popescu, Nicholas C; Goodison, Steve (2014) Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene. Mol Diagn Ther 18:293-302
Zhou, Xiaoling; Yang, Xu-Yu; Popescu, Nicholas C (2012) Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells. Biochem Biophys Res Commun 420:325-30
Zhou, Xiaoling; Zimonjic, Drazen B; Park, Sang-Won et al. (2008) DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. Int J Oncol 32:1285-91
Sedelnikova, Olga A; Horikawa, Izumi; Redon, Christophe et al. (2008) Delayed kinetics of DNA double-strand break processing in normal and pathological aging. Aging Cell 7:89-100
Guan, M; Tripathi, V; Zhou, X et al. (2008) Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy. Cancer Gene Ther 15:371-81
Durkin, M E; Ullmannova, V; Guan, M et al. (2007) Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth. Oncogene 26:4580-9
Qian, Xiaolan; Li, Guorong; Asmussen, Holly K et al. (2007) Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc Natl Acad Sci U S A 104:9012-7
Ullmannova, Veronika; Popescu, Nicholas C (2007) Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect Prev 31:110-8
Zhou, Xiaoling; Popescu, Nicholas C; Klein, George et al. (2007) The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. Cancer Genet Cytogenet 177:6-15
Min, J-N; Huang, L; Zimonjic, D B et al. (2007) Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 26:5086-97

Showing the most recent 10 out of 40 publications